HALO logo
halo search icon
ZEAL
Zealand Pharma A/S

ZEAL · Zealand Pharma A/S

309.40

DKK
-11.80 (-3.674%)
24/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

kr22.99B

PE

5.10

EV/EBITDA

2.6

DIV Yield

0%

Payout Ratio

0%

MQV Rating

2Strong

As at 24/08/2026 12:00:00 AM

Price Chart

Description

Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.

  • All-Companies
  • All-Consensus
  • Engulfing Bearish (Realtime)
  • HALO 100
  • HALO 50
  • HALO All
  • HALO Balance Sheet
  • HALO Earnings Momentum
  • HALO Small
  • HALO Value
  • Recent Earnings upgrade

Key Fundamentals

EPS 3 yr Growth

-538.10%

EBITDA Margin

78.00%

Operating Cashflow

kr6,532m

Free Cash Flow Return

54.00%

ROIC

53.30%

Interest Coverage

190.50

Quick Ratio

23.60

Performance

52 weeks range

Low 233.5 - 556

Trade Value (12mth)

US$5,842,870.00

1 week

0%

1 month

9.92%

YTD

-30.19%

1 year

-21.37%

All time high

972.00

Additional Data

Shares Outstanding (Fully Diluted)

71m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

DKK

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Strong

Garp

Weak

Mqv Small

Strong

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Van Herk Investments BVSubsidiary
Zealand Pharma A/SPublic Company
Adam Sinding SteensbergIndividual
Ivan M. MøllerIndividual
Christina Sonnenborg BredalIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Zealand Pharma A/S (ZEAL:CSE)?
Halo FAQ
The current share price of Zealand Pharma A/S (ZEAL:CSE) is DKKkr309.40.
2
What is the 52-week high share price for Zealand Pharma A/S (ZEAL:CSE)?
Halo FAQ
The 52-week high share price for Zealand Pharma A/S (ZEAL:CSE) is DKKkr556.00.
3
What is the 52-week low share price for Zealand Pharma A/S (ZEAL:CSE)?
Halo FAQ
The 52-week low share price for Zealand Pharma A/S (ZEAL:CSE) is DKKkr233.50.
4
What is the dividend yield for Zealand Pharma A/S (ZEAL:CSE)?
Halo FAQ
Zealand Pharma A/S (ZEAL:CSE) does not pay a dividend.
5
What was Zealand Pharma A/S (ZEAL:CSE) last dividend payment?
Halo FAQ
Zealand Pharma A/S (ZEAL:CSE) does not pay a dividend.
6
What is the franking level for Zealand Pharma A/S (ZEAL:CSE)?
Halo FAQ
Zealand Pharma A/S (ZEAL:CSE) has a franking level of 0.00%.
7
In which sector is Zealand Pharma A/S (ZEAL:CSE) classified?
Halo FAQ
Zealand Pharma A/S (ZEAL:CSE) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Zealand Pharma A/S (ZEAL:CSE)?
Halo FAQ
The current P/E ratio for Zealand Pharma A/S (ZEAL:CSE) is 5.10.